Pfizer Cost-Cut Initiatives More Than Offset Tariffs Impact, Raises Outlook

All NewsAugust 5, 2025

Pfizer posts better-than-expected Q2 earnings and sales, raises 2025 EPS outlook, and outlines $7.7 billion in cost-saving initiatives through 2027.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent